Vimarsana
Biggest News Aggregation in the World

Page 5 - Planet Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Planet Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Planet Communications Today - Breaking & Trending Today

CANbridge Pharmaceuticals Ltd Listed on Main Board of Hong Kong Stock Exchange - Vimarsana News

CANbridge Pharmaceuticals Ltd Listed on Main Board of Hong Kong Stock Exchange

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 9, 2021--

The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches - Vimarsana News

The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches - Vimarsana News

The Chinese Red Cross Foundation Rare Disease Mutual Assistance Fund Officially Launches

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
CANbridge Signs Collaboration Agreement with the Peking Union Medical College on Rare Disease Research - Vimarsana News

CANbridge Signs Collaboration Agreement with the Peking Union Medical College on Rare Disease Research

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration - Vimarsana News

CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration

Press release content from Business Wire. The AP news staff was not involved in its creation. CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration February 25, 2021 GMT BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 25, 2021-- CANbridge Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing drug candidates in China and North Asia, and Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, have agreed to terminate their 2018 license agreement, in which Puma granted CANbridge...

Source: apnews.com